Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanotech grant

This article was originally published in The Tan Sheet

Executive Summary

The National Institutes of Health awards a $1.6 million Research Project Grant to Luna Innovations to investigate the efficacy of fullerene-based nanomedicines in treating allergies and other inflammatory conditions, according to a July 22 release. Roanoke, Va.-based Luna says it modified fullerenes, a class of carbon molecules, to amplify the immune response in cells and "block the noxious effects of allergies." With the NIH funding, the health science developer intends to further explore systemic, cellular and molecular responses to fullerenes through in vivo and in vitro tests. NIH awarded the grant through its National Institute of General Medical Sciences and participates in the National Nanotechnology Initiative to evaluate nanomaterials (1"The Tan Sheet" Aug. 14, 2006, p. 7)...
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS101924

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel